These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4935137)

  • 41. Obesity--the health hazard of our time.
    Sedgwick JP
    S Afr Med J; 1971 Apr; 45(14):362-70. PubMed ID: 4930511
    [No Abstract]   [Full Text] [Related]  

  • 42. [Therapeutic effect of various appetite depressants under controlled conditions].
    Kreze A; Toman A
    Bratisl Lek Listy; 1973; 59(4):406-12. PubMed ID: 4751882
    [No Abstract]   [Full Text] [Related]  

  • 43. A clinical trial of fenfluramine.
    Traherne JB
    Practitioner; 1965 Nov; 195(169):677-80. PubMed ID: 5321366
    [No Abstract]   [Full Text] [Related]  

  • 44. [Increase of energy transformation by hexoprenaline].
    Irsigler K; Schlick W; Schütz P
    Arzneimittelforschung; 1971 Jan; 21(1):51-4. PubMed ID: 5108200
    [No Abstract]   [Full Text] [Related]  

  • 45. Anti-lipaemic effect of Desopimon in obesity and in diabetes mellitus accompanied by obesity.
    Less E
    Ther Hung; 1974; 22(1):27-31. PubMed ID: 4844928
    [No Abstract]   [Full Text] [Related]  

  • 46. Weighing benefits and risks of drug to treat obesity.
    Sukkari SR
    CMAJ; 1997 Mar; 156(6):768-9. PubMed ID: 9084379
    [No Abstract]   [Full Text] [Related]  

  • 47. Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity.
    Defelice EA; Chaykin LB; Cohen A
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):358-66. PubMed ID: 4198296
    [No Abstract]   [Full Text] [Related]  

  • 48. The pharmacologic management of obesity.
    Cerda JJ
    J Fla Med Assoc; 1997 Feb; 84(2):89-92. PubMed ID: 9066231
    [No Abstract]   [Full Text] [Related]  

  • 49. With new diet drug, challenge is weighing patient demand and potential benefit.
    Jones L
    Ann Intern Med; 1996 Aug; 125(4):I58. PubMed ID: 9446497
    [No Abstract]   [Full Text] [Related]  

  • 50. Sebum excretion rate and biochemistry in patients with acne vulgaris treated by oral fenfluramine.
    Cotterill JA; Cunliffe WJ; Williamson B
    Br J Dermatol; 1971 Aug; 85(2):127-9. PubMed ID: 4255130
    [No Abstract]   [Full Text] [Related]  

  • 51. Somatometric and hormonal effects of dexfenfluramine.
    Sonka J; Marek J; Svacina S; Sucharda P; Stĕpán J
    Sb Lek; 1995; 96(4):299-301. PubMed ID: 8711372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Controlled clinical trials of a new appetite-inhibiting drug].
    Bani G; Barba C; Ricci G
    Clin Ter; 1968 Oct; 47(2):161-74. PubMed ID: 5702726
    [No Abstract]   [Full Text] [Related]  

  • 53. After fen-phen.
    Cowley G; Springen K
    Newsweek; 1997 Sep; 130(13):46-8. PubMed ID: 10173270
    [No Abstract]   [Full Text] [Related]  

  • 54. [Electroencephalographic and statokinesimetric study of perphoxene in man].
    Soulairac A
    Therapeutique; 1971 Apr; 47(4):365-9. PubMed ID: 5564048
    [No Abstract]   [Full Text] [Related]  

  • 55. Appetite suppressants for obesity.
    Budenholzer B
    J Fam Pract; 1997 Jan; 44(1):19-20. PubMed ID: 9010359
    [No Abstract]   [Full Text] [Related]  

  • 56. New treatment for obesity: dexfenfluramine (Redux).
    Bihm B
    Medsurg Nurs; 1996 Oct; 5(5):360-2, 373. PubMed ID: 8981871
    [No Abstract]   [Full Text] [Related]  

  • 57. Fenfluramine: study of its central action through its effects on sleep.
    Gagnon MA; Bordeleau JM; Tétreault L
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jan; 2(1):74-82. PubMed ID: 4894948
    [No Abstract]   [Full Text] [Related]  

  • 58. [Trial of benzphetamine in treatment of obesity].
    Plauchu M; Chapuy H; Pousset G; Amourdedieu J; Tuaillon J
    Lyon Med; 1969 Sep; 222(32):317-20. PubMed ID: 5398817
    [No Abstract]   [Full Text] [Related]  

  • 59. [The treatment of the obese non-insulin-dependent patient with d-fenfluramine].
    Daniele E; Coco MP
    Clin Ter; 1996 Apr; 147(4):199-204. PubMed ID: 8766352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Ponderal Retard].
    de Longraye J
    Soins; 1985 Feb; (448):III-IV. PubMed ID: 3847130
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.